Elsevier

Life Sciences

Volume 56, Issues 23–24, 5 May 1995, Pages 2033-2040
Life Sciences

Cannabinod receptor and their ligand
The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

https://doi.org/10.1016/0024-3205(95)00186-AGet rights and content

Abstract

The present study has been designed to test whether the recently described endogenous ligand for the cannabinoid receptor, arachidonylethanolamide, termed anandamide, can mimic the effects produced by exogenous cannabinoids on motor behavior and to test possible neurochemical substrates for this potential effect. To this end, adult male rats were submitted to an acute i.p. injection of anandamide, Δ9-tetrahydrocannabinol (THC) or vehicle. Animals were behaviorally tested ten minutes after injection of the drug and, then, sacrificed and their brains used for dopaminergic analyses. Ambulation was not significantly affected by the treatment with either THC or anandamide, but a very pronounced increase was observed in the time spent in inactivity in rats treated with either THC or anandamide. This was accompanied by a marked decrease in the frequency of spontaneous non-ambulatory activities, such as grooming and rearing, although only the administration of THC decreased shaking behavior. The anandamide-induced decrease in grooming was dose-dependent, but the decrease in rearing was higher with the dose of 3 mg/kg than with the dose of 10 mg/kg. The administration of anandamide also caused a dose-dependent decrease in the activity of tyrosine hydroxylase and in the ratio between the number of D1 and D2 receptors in the striatum. Moreover, the administration of 3 mg/kg of anandamide significantly decreased the contents of dopamine and L-3,4-dihydroxyphenylacetic acid in the striatum although lesser and higher doses were less effective. THC only tended to decrease these parameters. No changes were seen in dopaminergic activity in the limbic forebrain after either cannabimimetics. In summary, anandamide, as well as THC, decreases motor behavior. This effect was paralleled by a reduction in the activity of nigrostriatal dopaminergic neurons. However, subtle differences in the behavioral and neurochemical effects between anandamide and THC could be observed.

References (27)

  • A.C. Howlett et al.

    TINS

    (1990)
  • E. Fride et al.

    Eur. J. Pharmacol.

    (1993)
  • M. Herkenham et al.

    Brain Res.

    (1991)
  • M. Navarro et al.

    Pharmacol. Biochem. Behav.

    (1993)
  • D.F. Moss et al.

    Pharmacol. Biochem. Behav.

    (1981)
  • M. Navarro et al.

    Pharmacol. Biochem. Behav.

    (1994)
  • J.J. Fernandez-Ruiz et al.

    J. Steroid Biochem.

    (1989)
  • T. Nagatsu et al.

    J. Chromat.

    (1979)
  • O.H. Lowry et al.

    J. Biol. Chem.

    (1951)
  • A. Oviedo et al.

    Brain Res.

    (1993)
  • J.N. Crawley et al.

    Pharmacol. Biochem. Behav.

    (1993)
  • A.P. Wickens et al.

    Eur. J. Pharmacol.

    (1993)
  • W.A. Devane et al.

    Science

    (1992)
  • Cited by (100)

    • Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ<inf>1–42</inf>-treated mice

      2016, Neurobiology of Learning and Memory
      Citation Excerpt :

      CB1 receptor protein is abundant in the basal ganglia and cerebellum, both of which are involved in the initiation and coordination of movement (Elphick & Egertova, 2001). CB1 receptor ligands have been reported to modulate locomotor activity, and most studies that have addressed this question have indicated that activation of the CB1 receptor suppresses locomotor activity (Romero et al., 1995; Soderstrom & Johnson, 2001), physical activity has been shown to increase the hippocampal function and improve memory in human and animals (Cotman & Berchtold, 2002; Creer, Romberg, Saksida, van Praag, & Bussey, 2010; Erickson et al., 2011; van Praag, Shubert, Zhao, & Gage, 2005). Thus, the memory-modulating effects of CB1 receptor ligands might be related to changes in the animals’ movement.

    • Cannabinoids and Huntington's disease

      2015, Cannabinoids in Neurologic and Mental Disease
    View all citing articles on Scopus
    View full text